3Harris D. Mad cow disease and related spongiform eneephalopathies.Springer-verlag Berlin Heidelberg press, New York,2004.
4Pawitan Y., Griffin JM., Collins JD. Analysis and prediction of the BSE incidence in Ireland. Preventive Veterinary Medicine, 2004,62(4): 267-283.
5Finberg KE. Mad cow disease in the United States: an update on bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Clinical Microbiology Newsletter, 2004, 26(15): 113-118.
6Berg L. Trust in food in the age of mad cow disease: a comparative study of consumers" evaluation of food safety in Belgium, Britain and Norway. Appetite, 2004, 42(1): 21-32.
7Mabbott NA. The complement system in prion diseases. Current Opinion in Immunology, 2004, 16(5): 587-593.
8Heppner FL., Aguzzi A. Recent developments in prion immunotherapy. Current Opinion in Immunology, 2004, 16(5): 594-598.
9Wilson C., Hughes L., Rashid T., Cunningham P., Bansal S.,Ebringer A., Ettelaie C. Antibodies to prion and Acinetobacter peptide sequences in bovine spongiform encephalopathy. Veterinary Immunology and Immunopathology, 2004, 98(1-2): 1-7.
10Ye ilba K., Kalkan A. Detection of central nervous system tissues as BSE specified risk material in meat products in Turkey. Food Control, 2005, 16(1): 11 -13.
